Matsuoka Yuichiro, Yoshida Ryoji, Nakayama Hideki, Nagata Masashi, Hirosue Akiyuki, Tanaka Takuya, Kawahara Kenta, Nakagawa Yoshihiro, Sakata Jyunki, Arita Hidetaka, Hiraki Akimitsu, Shinohara Masanori
Departments of Oral and Maxillofacial Surgery, Kumamoto University Graduate School of Life Sciences, Kumamoto, Japan.
APMIS. 2015 Mar;123(3):205-14. doi: 10.1111/apm.12344. Epub 2014 Dec 31.
It has been increasingly recognized that the tumour microenvironment is a critical factor involved in cancer progression. However, little is known about the clinical value of the stromal features in oral squamous cell carcinoma (OSCC). The purpose of this study was to determine the clinical significance of cancer-associated fibroblasts (CAFs) and tumour-associated macrophages (TAMs) in OSCC. OSCC specimens were obtained from 60 patients who underwent surgery following 5-fluorouracil-based chemoradiotherapy. Paraffin-embedded sections obtained from biopsy specimens were immunohistochemically analysed. The associations among CAFs, TAMs and various clinicopathological features were examined, and the effects of CAFs and TAMs on the prognosis were evaluated. In the group with a high level of CAFs, the incidence of advanced pT- and pN-stage cases was significantly higher than that in the group with the low level. A high TAMs tumour expression was significantly correlated with a poor response to preoperative chemoradiotherapy. A Kaplan-Meier analysis revealed that higher numbers of CAFs and TAMs were significantly correlated with a poor prognosis. These findings suggest that TAMs are a potential biomarker for predicting the clinical response to 5-FU-based chemoradiotherapy, and the expression status of the CAFs and TAMs may be useful for making treatment decisions to improve the survival of OSCC patients.
越来越多的人认识到肿瘤微环境是癌症进展的关键因素。然而,关于口腔鳞状细胞癌(OSCC)中基质特征的临床价值却知之甚少。本研究的目的是确定癌症相关成纤维细胞(CAFs)和肿瘤相关巨噬细胞(TAMs)在OSCC中的临床意义。OSCC标本取自60例接受基于5-氟尿嘧啶的放化疗后手术的患者。对活检标本的石蜡包埋切片进行免疫组化分析。研究了CAFs、TAMs与各种临床病理特征之间的关联,并评估了CAFs和TAMs对预后的影响。在CAFs水平高的组中,晚期pT和pN分期病例的发生率显著高于水平低的组。TAMs高肿瘤表达与术前放化疗反应差显著相关。Kaplan-Meier分析显示,CAFs和TAMs数量较多与预后不良显著相关。这些发现表明,TAMs是预测基于5-FU的放化疗临床反应的潜在生物标志物,CAFs和TAMs的表达状态可能有助于做出治疗决策,以提高OSCC患者的生存率。